1.
Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations
by Kotronen, A
Diabetologia, 2009-02-13, Vol.52 (4), p.684-690
2.
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
by Kotronen, A
Diabetologia, 2009-02-18, Vol.52 (6), p.1056-1060
3.
Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome
by Kotronen, A
Diabetologia, 2007-11-16, Vol.51 (1), p.130-138
4.
Insulin-Like Growth Factor Binding Protein 1 as a Novel Specific Marker of Hepatic Insulin Sensitivity
by Kotronen, Anna
The journal of clinical endocrinology and metabolism, 2008-12, Vol.93 (12), p.4867-4872
5.
Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation
by Tammela, Tuomas
Nature medicine, 2007-12, Vol.13 (12), p.1458-1466
6.
Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids
by Oresic, Matej
Diabetologia, 2013-10, Vol.56 (10), p.2266-2274
7.
Liver Fat in the Metabolic Syndrome
by Kotronen, Anna
The journal of clinical endocrinology and metabolism, 2007-09, Vol.92 (9), p.3490-3497
8.
Rosiglitazone Reduces Liver Fat and Insulin Requirements and Improves Hepatic Insulin Sensitivity and Glycemic Control in Patients with Type 2 Diabetes Requiring High Insulin Doses
by Juurinen, Leena
The journal of clinical endocrinology and metabolism, 2008-01, Vol.93 (1), p.118-124
